NCT03355534View on ClinicalTrials.gov

Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Aneurysm Cerebral
Interventions
DRUG

Intravenous dexmedetomidine

drug is intravenously infused to patients

DRUG

nasal dexmedetomidine

drug is nasally given to patients

DRUG

intravenous saline

saline is given to patients intravenously

DRUG

nasal saline

normal saline is given to patients nasally

Trial Locations (1)

710032

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Zhihong LU

OTHER

NCT03355534 - Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery | Biotech Hunter | Biotech Hunter